iShares US Pharmaceuticals ETF
ETFYour view on IHE

iShares US Pharmaceuticals ETF
ETFISharesSentiment
AUM (USD)
$1.65B
Expense Ratio
0.37%
Yield (TTM)
1.34%
Holdings
52
Sentiment
Overview
What the fund invests in, who runs it, and what it costs.
iShares US Pharmaceuticals ETF (IHE) is an Equity fund from iShares, listed since 2006, with $1.7B in assets under management, a 0.37% expense ratio and a NAV of $106.55 USD.
Overview for iShares US Pharmaceuticals ETF
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 1, 2006
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 1, 2006
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 1, 2006
- Domicile
- US
About this fund
The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
Price Chart
Market price history and trading volume.
Key Facts
Cost, yield, size, and the fund's reference data.
Expense Ratio
0.37%
Yield (TTM)
1.34%
AUM
$1.65B
Fund Details
Expense Ratio
0.37%
Dividend Yield (TTM)
1.34%
Assets Under Management
$1.65B
NAV
$106.55 USD
Holdings
52
Average Volume
270.7K
Inception Date
May 1, 2006
Asset Class
Equity
Fund Issuer
IShares
Domicile
US
ISIN
US4642888360
CUSIP
464288836
NAV Currency
USD
Expense Ratio
0.37%
Dividend Yield (TTM)
1.34%
Assets Under Management
$1.65B
NAV
$106.55 USD
Holdings
52
Average Volume
270.7K
Inception Date
May 1, 2006
Asset Class
Equity
Fund Issuer
IShares
Domicile
US
ISIN
US4642888360
CUSIP
464288836
NAV Currency
USD
Distributions · last 12 months
Quarterly · 4 payments
| Ex-date | Paid | Amount |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.2789 |
| Jun 15, 2026 | Jun 18, 2026 | $0.2848 |
| Mar 17, 2026 | Mar 20, 2026 | $0.2845 |
| Dec 16, 2025 | Dec 19, 2025 | $0.5853 |
| Total, 12 months | $1.43 a share | |
Dividend yield (TTM) 1.34% = $1.43 paid per share in the 12 months to Nov 20, 2026 ÷ the $107.05 price. Past distributions; future payments can differ.
Sectors
How the fund's assets are split across sectors.
- 1Pharmaceuticals99.9%
- 2Cash and/or Derivatives0.1%
Top sector
Pharmaceuticals
Top weight
99.9%
Top 3 weight
100.0%
Holdings
The securities the fund owns, by weight.
Concentration
Total Holdings
54
Top 10 Weight
81.60%
Top Holding
LLY
Top Weight
26.40%
Total Holdings
54
Top 10 Weight
81.60%
Top Holding
LLY
Top Weight
26.40%
Comparables
Funds similar to this one.
Comparable funds
- BKMCBNY Mellon US Mid Cap Core Equity ETFEquity0.04%$657M403
- DWMWisdomTree International Equity FundInternational Equity0.48%$651M1,339
- IGEiShares North American Natural Resources ETFEquity0.37%$777M149
- INDYiShares India 50 ETFEquity0.65%$596M50
- IYMiShares US Basic Materials ETFEquity0.37%$1.2B40
- IYZiShares U.S. Telecommunications ETFEquity0.37%$661M22
- KSAiShares MSCI Saudi Arabia ETFEquity0.75%$557M109
- PPHVanEck Pharmaceutical ETFEquity0.36%$1.1B26
More IShares ETFs
- IBTGiShares iBonds Dec 2026 Term Treasury ETFFixed Income0.07%$1.8B7
- IBTHiShares iBonds Dec 2027 Term Treasury ETFFixed Income0.07%$2.4B51
- IBTIiShares iBonds Dec 2028 Term Treasury ETFFixed Income0.07%$2.3B48
- IBTJiShares iBonds Dec 2029 Term Treasury ETFFixed Income0.07%$1.6B38
- IBTKiShares iBonds Dec 2030 Term Treasury ETFFixed Income0.07%$1.2B26
- IBTLiShares iBonds Dec 2031 Term Treasury ETFFixed Income0.07%$793M26
- IBTMiShares iBonds Dec 2032 Term Treasury ETFFixed Income0.07%$639M15
- IBTOiShares iBonds Dec 2033 Term Treasury ETFFixed Income0.07%$520M13
- IBTPiShares iBonds Dec 2034 Term Treasury ETFFixed Income0.07%$375M4
- IBTQiShares iBonds Dec 2035 Term Treasury ETFFixed Income0.07%$296M4
- IBTRiShares iBonds Dec 2036 Term Treasury ETFFixed Income0.07%$111M4
- ICFiShares Select U.S. REIT ETFReal Estate (Listed/REITs)0.32%$2.0B30
Fund Holders
Institutions that own shares of this fund.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.